Gerresheimer’s Post

In the first half-year of 2024 revenue grew organically by 1.7%, adjusted EBITDA by 2.9%. For the 2nd half of FY 2024, Gerresheimer expects a significant upturn in business owing to new production lines ramping up and destocking effects fading out. Guidance for 2024 (organic) - Revenue growth: 5 - 10% - Adjusted EBITDA: EUR 430m - 450m - Adjusted EPS growth: 8 -12% Read our Half-year financial report https://lnkd.in/e8dQc6At #H1results #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery 

🚨Reading Alert🚨 Check out the newest article 'Filling Unit Operation for #Biological Drug Products: Challenges and Considerations' authored by our colleagues PD Dr. Andrea Allmendinger and Michael Adler. This review article focuses on challenges associated with filling operations of biologics. 🤓 What's it about? The review provides an overview of commonly used filling technologies for #biologics, describing the operating principle of each pump system and reviewing advantages and drawbacks. The authors focus on challenges related to #protein particle formation and #particle shedding from wear and tear of tubing, and discuss current literature about general challenges associated with the filling process, such as hydrogen peroxide uptake, adsorption phenomena to tubing material, and needle clogging. ⚠️ The article is completed with process development and process characterization studies to assess the impact of the filling process on product quality. Here's the link to the pdf - ‼️ATTENTION‼️ : only is accessible until Jan 25th: https://lnkd.in/e8UGu29c Enjoy the reading! 😄 #ten23health #article #biologics #cdmo #drugproduct #aseptic #sterile #pharma

Here are the answers to the #GlobalBiosimilarWeek Quiz! Did you get the answers right? It is estimated that in the span of 2017 to 2026, the US #Biosimilar Market will reduce the direct spending on #Biologics by $54 billion. Biosimilars are proving to be an effective way to reduce healthcare costs and increase access to affordable medications for several life-threatening conditions. References: https://lnkd.in/dQkbthC  https://lnkd.in/d47av-T  Ratnesh Jain | Prajakta Dandekar | Institute Of Chemical Technology #research #scicomm #biopharma #academia #pharma #innovation #healthtech #sciencematters #BiosimilarsAwareness #BiosimilarsValue #monoclonalantibodies #triviatuesday

𝗖𝗗𝗠𝗢 𝗟𝗜𝗩𝗘! 🧬💊 The US market is set to reach $68.32 Billion USD by 2029, followed by China, India and Germany. Canada is also a significant market for CDMOs, expected to reach $7.88 Billion. Accounting for almost 50% of the global pharma revenue, North America is not slowing down but has the most modest growth out of all the regions. 𝗖𝗗𝗠𝗢 𝗟𝗶𝘃𝗲 𝗶𝘀 𝘁𝗵𝗲 𝘂𝗹𝘁𝗶𝗺𝗮𝘁𝗲 𝗼𝗻𝗹𝗶𝗻𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴 𝗲𝘃𝗲𝗻𝘁 𝗳𝗼𝗿 𝗯𝗶𝗼/𝗽𝗵𝗮𝗿𝗺𝗮 𝗼𝘂𝘁𝘀𝗼𝘂𝗿𝗰𝗶𝗻𝗴. There are many expert speakers scheduled for the event to which will make for an interesting listen. Will you be registering and keeping up with all the latest news and hot topics? #CDMO #Biologics #PharmaManufacturing #MasonHarding Infographic below by PharmaSource 🙏🏽

This month’s #sales #compensation tip uncovers a primary drawback of scoring MBOs on a five-point scale, and outlines an alternative scoring model designed to more accurately capture differences in performance. Read more tips exclusively for #biopharma sales compensation at: https://lnkd.in/gKisXqT   #pharmaceuticals #biotechnology #medicaldevices #lifesciences #innovation #motivation #consulting #strategy #productivity #business

📢 Revolutionary Techniques Boost Biosimilar Adoption and Cut Costs 🔍 A biosimilar manufacturer is focusing on process optimization to increase the adoption of its products in lower-income countries. This optimization includes techniques such as intensified perfusion, CO2 stripping, and metabolomic analysis to reduce costs and improve yields. Process optimization is important for biosimilars as it helps achieve high yields while maintaining potency and safety. The company will be discussing these techniques at the Bioprocessing Summit in Boston. #BioprocessUpdates #biosimilar #processoptimization #manufacturing #lowerincomecountries #intensifiedperfusion #CO2stripping #metabolomicanalysis #costreduction #improveyields #potencyandsafety #bioprocessingsummit #biotechindustry #pharmaceuticals #innovation #biomanufacturing ▷ Read the full article here: 📎 https://lnkd.in/dCx2N-S8

With sustainability being the top concern of our Pharma Clients, we present the LMAS 1.0 data integrity software. Go Paperless with the LMAS and protect the environment. www.erfolgganar.com #Pharmaceutical #DataIntegrity #Biotechnology #21CFRPart11Ready #Microbiology #Sustainability #Tech #USFDA #WorldEnvironmentDay #ClimateChange

LMAS gives you the power of Digital.

NEW White Paper | Risk-Based E&L Strategies for Bioprocessing Single-Use Systems. Navigating USP<655>/<1665>, BPOG & other guidance for safe & effective biologics ⬇️ The biopharmaceutical industry has widely adopted single-use systems (SUS) for their efficiency, reduced contamination risk, and streamlined validation. SUS applications range from media bags and tubing to connectors, filters, columns, and bioreactors. While these innovations enhance production and minimize risks, leachables from the plastic materials may compromise product quality and end-user safety. Consequently, extractables and leachables studies on process components are mandatory, but navigating the relevant guidance, such as that from USP <655>/<1665> or BioPhorum Operations Group, can be complex. This white paper delves into the risks due to leachables associated with bioprocessing SUS and explores risk-based strategies for their mitigation. We will navigate the evolving regulatory landscape and explore best practices for extractables and leachables (E&L) testing. Download our white paper now to get the knowledge you need to ensure the safety and quality of your biopharmaceutical products in the era of single-use technology: https://lnkd.in/ecd_EeX5 #ExtractablesAndLeachables #SingleUseSystems #ProductQuality #biologics #biopharmaceuticals

To stress or not to stress, that is the question! Watch our #webinar with Owen Griffin for an evaluation of stressed microorganisms and their impact on time-to-result (TTR) in #pharmaceutical manufacturing. #microbiology